TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis August 23, 1974
TCL Archive XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program July 30, 1982
TCL Archive International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials August 29, 2014
TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
